Introduction
According to the World Health Organization, corneal diseases are a major cause of vision loss and blindness, second only to cataract in overall importance [1] . It is estimated that ocular trauma and corneal ulceration result in 1.5 to 2 million new cases of corneal blindness annually.
Epidemiology
Fungal keratitis is a major blinding eye disease in Asia. One report from South India found that 44% of all central corneal ulcers are caused by fungi [2] . This high prevalence of fungal pathogens in South India is significantly greater than that found in similar studies in Nepal (17%), Bangladesh (36%), Ghana (37.6%), and south Florida (35%) [3] [4] [5] [6] [7] . In China, the incidence of fungal keratitis has increased during the past decade [8] . In temperate climates, such as Britain and the northern United States, the incidence of fungal keratitis remains very low [9, 10] .
Predisposing factors
Local predisposing factors include trauma, contact lenses, and topical steroids.
Trauma
Injury to the cornea is the leading cause of microbial keratitis, particularly fungal keratitis. A history of corneal trauma with vegetable matter or organic matter is reported in 55 to 65% of fungal keratitis (11,12••,13]. A study from the northern United States reported trauma as the inciting event in only 8.3% of cases [14] . In the southern United States, trauma was identified as a principal risk factor in 44% of children who had microbial keratitis and 27% among 227 cases of microbial keratitis reported in a nonreferral county practice in southern California [15, 16] .
Contact lenses
Several case reports published recently have identified contact lens wear as a risk factor for fungal keratitis in industrialized countries (29%) [17] . Patients wearing any type of contact lens can get fungal keratitis [18] .
Topical steroid use
Many ophthalmologists identify topical steroids as the principal risk factor in enhancing ocular fungal growth. Steroid use as initial therapy was reported in 1 to 30% of patients having microbial keratitis [ 
Clinical features
Bharathi et al. [12••] reported a large series of fungal ulcers (1095) occurring in South India. In this study, male patients were affected more commonly than female patients. Approximately 65% of patients were in the age group of 21 to 50 years.
For several decades, the fungal ulcer has been described as indolent and dry, with a leathery, tough, raised surface [12••,27,28••]. In this author's experience in treating several hundred fungal ulcers, the clinical features do not always correlate with classic textbook descriptions. The early fungal ulcer will appear like a dendritic ulcer of herpes simplex virus origin (Fig. 1) . The signs of inflammation will be minimal in comparison with bacterial keratitis. The absence of lid edema is a common feature. The infiltrates appear grayish-white or yellowishwhite, and the base of the ulcer is often filled with soft, creamy, raised exudates, making it very easy to scrape the material even with a Kimura spatula.
Feathery borders or hyphate edges (Fig. 2) (Fig. 3 ), which appears dry, rough, and leathery; it can be difficult to obtain scrapings for culture using a spatula. An immune ring (Fig. 4) , satellite lesions, and posterior corneal abscess are seen infrequently ( 
Laboratory diagnosis
Laboratory diagnosis can be made by means of smear, staining, fungal culture, polymerase chain reaction, and confocal microscopy. Gram stain will identify fungal species in 45 to 73% of cases, and Giemsa will identify fungi in 66%. Lactophenol cotton blue has a sensitivity of 70 to 80%, Grocott methenamine silver staining of as much as 89%, and calcofluor white of 80 to 90%.
There have been differing reports on the sensitivity of the potassium hydroxide (KOH) smear. A retrospective study [12] of 3183 corneal ulcers reported that the sensitivity of the 10% KOH wet mount (Fig. 6 ) was higher (99.23%) than that of the Gram stained smear (88.73%) (Fig. 7 ) in the detection of fungal keratitis. Another study from South India reported equivalent sensitivities when 10% KOH smear (90%) was compared with calcofluor white (91%) (24). Conversely, Liesegang and Forster [7] and Forster and Rebell [31] have reported much lower sensitivities (5 to 33%) when using KOH .
In our experience, 10% KOH wet mount is simple, cheap, rapid, and easy to interpret even by ophthalmic technicians. It is an ideal method for practice in tropical and developing countries. 
New diagnostic tools
Although polymerase chain reaction (PCR) and confocal microscopy are being used as new rapid diagnostic methods; they are not available in areas where fungal keratitis is highly prevalent. 
Medical therapy
Currently, the therapy of fungal disease of the eye is unsatisfactory. The antifungal agents available today are mostly fungistatic, requiring a prolonged course of therapy. Although models of Aspergillus and Candida have been established, there are no reliable animal models of Fusarium keratitis. Fungi considered to be ocular pathogens are rarely encountered among the systemic mycoses. Thus, the therapeutic principles valid for systemic fungal infections may not apply to the cornea [37] .
Polyenes
The polyenes include natamycin and amphotericin B. prospective study comparing the efficacy of natamycin 5% and econazole 2% in 112 cases of culture-proved fungal keratitis and found no statistically significant difference between the two drugs. Moreover, natamycin is very costly; the supply is erratic, and it is difficult to obtain in the third world.
Amphotericin B
Amphotericin B is available as a systemic preparation. To prepare the topical form, the compound is diluted with dextrose or distilled water to arrive at a 0.15 to 0.5% concentration (Fungizone, Sarabai Piramol, Vadodara, India). It can also be used through the subconjunctival (10 µg), intracameral (5-7.5 µg), intravitreal (10 µg) and intravenous routes (0.1 mg/kg body weight). The penetration of topically applied amphotericin B is poor in cornea with intact epithelium. The spectrum of activity of amphotericin B covers Candida species and Aspergillus species. It is not effective against Fusarium species [39] .
Azole compounds
The azole compounds include triazole, clotrimazole, the imidazoles, fluconazole, and voriconazole.
Triazole
Econazole 1% in arachis oil is available as an ophthalmic preparation in India (Aurozole, Aurolab, Madurai, India).
Prajna et al. [38••] have found that the effect of this drug is equal to that of natamycin against filamentous fungi.

Clotrimazole
Clotrimazole is also available as a 1% topical preparation as drops and in ointment form (Auroclot, Aurolab, Madurai, India) (Nistin-C, Jawa Pharmaceuticals, India). Mselle [40] treated 12 patients with proven fungal keratitis with clotrimazole but suggested that clotrimazole as monotherapy is not an ideal choice.
Imidazoles
Whereas the imidazoles, miconazole and ketoconazole, have less systemic toxicity, they are inferior to amphotericin B [41] . Because of relatively reduced systemic toxicity and better corneal penetration, these compounds can be used systemically for keratomycosis. Thomas et al.
[28••] over a period of 10 years (1984-1994) treated 330 cultured-proved fungal keratitis cases with ketoconazole, itraconazole, amphotericin B, and natamycin and found that 69% of patients responded to ketoconazole, 66% to itraconazole, 53% to amphotericin B, and 56% to natamycin. In severe keratitis it was less than 60% in all the groups. Fusarium is common in this region. 
Surgical therapy
The use of N-butyl cyanoacrylate tissue adhesive in the management of corneal thinning or perforation associated with active fungal keratitis has been reported [49•]. In a study of 73 patients, 63% showed resolution of infiltration with scar formation. Xie et al. [50] have tried lamellar keratoplasty. Amniotic membrane transplantation promotes healing and reduces inflammation in suppurative keratitis. Penetrating keratoplasty is the ideal method to treat nonhealing fungal keratitis threatening perforation. Structural integrity and eradication of sepsis is achieved in 80 to 90% of eyes and graft clarity in 36 to 89% [51,52,53•].
Conclusion
Fungal keratitis is responsible for a significant burden of blinding disease in the developing world. Current treatment methods frequently fail to preserve or restore vision after fungal keratitis. Although emerging antifungal agents show promise, therapeutic gaps will probably persist, and further development is necessary. Priorities should be given to develop and undertake drug trials against filamentous fungal keratitis. Basic research about the role of cytokines in corneal inflammation and tissue destruction should be encouraged. This author has published several articles on fungal keratitis and has vast knowledge of the laboratory diagnosis of microbial keratitis. This article highlights the sensitivity of various stains. Gram stain will identify fungal species in 45 to 73% of cases, and Giemsa stain will identify fungi in 66%. Lactophenol cotton blue has a sensitivity of 70 to 80%. The author suggests that the current treatment regimens for mycotic keratitis need to be modified. . Well-conducted prospective study having similar parameters about age, sex, size of ulcer, and etiologic agents. There was no statistical difference in efficacy against any of the fungi encountered in the study: 57% was Fusarium species and 67% of cases were cured.
